202 related articles for article (PubMed ID: 36418517)
21. Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.
Yee DS; Shariat SF; Lowrance WT; Maschino AC; Savage CJ; Cronin AM; Scardino PT; Eastham JA
BJU Int; 2011 Aug; 108(4):502-7. PubMed ID: 21050364
[TBL] [Abstract][Full Text] [Related]
22. Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy.
Liu YL; Saraf A; Lee SM; Zhong X; Hibshoosh H; Kalinsky K; Connolly EP
Breast Cancer Res Treat; 2016 Jun; 157(3):555-64. PubMed ID: 27225388
[TBL] [Abstract][Full Text] [Related]
23. Lymphovascular invasion can be better than pathologic complete response to predict prognosis in breast cancer treated with neoadjuvant chemotherapy.
Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
Medicine (Baltimore); 2018 Jul; 97(30):e11647. PubMed ID: 30045313
[TBL] [Abstract][Full Text] [Related]
24. Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response.
Asaoka M; Patnaik SK; Zhang F; Ishikawa T; Takabe K
Breast Cancer Res Treat; 2020 Jun; 181(2):309-322. PubMed ID: 32285241
[TBL] [Abstract][Full Text] [Related]
25. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
[TBL] [Abstract][Full Text] [Related]
26. An evaluation of lymphovascular invasion in relation to biology and prognosis according to subtypes in invasive breast cancer.
Nishimura R; Osako T; Okumura Y; Nakano M; Ohtsuka H; Fujisue M; Arima N
Oncol Lett; 2022 Aug; 24(2):245. PubMed ID: 35761943
[TBL] [Abstract][Full Text] [Related]
27. The role of lymphovascular invasion as a prognostic factor in patients with lymph node-positive operable invasive breast cancer.
Song YJ; Shin SH; Cho JS; Park MH; Yoon JH; Jegal YJ
J Breast Cancer; 2011 Sep; 14(3):198-203. PubMed ID: 22031801
[TBL] [Abstract][Full Text] [Related]
28. Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer.
Kariri YA; Joseph C; Alsaleem MA; Elsharawy KA; Alsaeed S; Toss MS; Mongan NP; Green AR; Rakha EA
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428736
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer.
Schoppmann SF; Bayer G; Aumayr K; Taucher S; Geleff S; Rudas M; Kubista E; Hausmaninger H; Samonigg H; Gnant M; Jakesz R; Horvat R;
Ann Surg; 2004 Aug; 240(2):306-12. PubMed ID: 15273556
[TBL] [Abstract][Full Text] [Related]
30. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study.
Van den Eynden GG; Van der Auwera I; Van Laere SJ; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
Br J Cancer; 2006 Jun; 94(11):1643-9. PubMed ID: 16670715
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of lymphovascular invasion in colorectal cancer and its association with genomic alterations.
Jiang HH; Zhang ZY; Wang XY; Tang X; Liu HL; Wang AL; Li HG; Tang EJ; Lin MB
World J Gastroenterol; 2019 May; 25(20):2489-2502. PubMed ID: 31171892
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement.
Ugras S; Stempel M; Patil S; Morrow M
Ann Surg Oncol; 2014 Nov; 21(12):3780-6. PubMed ID: 24952028
[TBL] [Abstract][Full Text] [Related]
33. Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer.
Elsharawy KA; Althobiti M; Mohammed OJ; Aljohani AI; Toss MS; Green AR; Rakha EA
Breast Cancer Res Treat; 2021 Feb; 185(3):615-627. PubMed ID: 33161513
[TBL] [Abstract][Full Text] [Related]
34. The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.
Aleskandarany MA; Agarwal D; Negm OH; Ball G; Elmouna A; Ashankyty I; Nuglozeh E; Fazaludeen MF; Diez-Rodriguez M; Nolan CC; Tighe PJ; Green AR; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2016 Feb; 156(1):9-20. PubMed ID: 26907764
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.
Kurozumi S; Joseph C; Sonbul S; Aleskandarany MA; Pigera M; Alsaleem M; Alsaeed S; Kariri Y; Nolan CC; Diez-Rodriguez M; Johnston S; Mongan NP; Fujii T; Shirabe K; Martin SG; Ellis IO; Green AR; Rakha EA
Breast Cancer Res Treat; 2018 Nov; 172(1):61-68. PubMed ID: 30056565
[TBL] [Abstract][Full Text] [Related]
36. Lymphovascular invasion, as a prognostic marker in patients with invasive breast cancer.
Gurleyik G; Gurleyik E; Aker F; Aktekin A; Emir S; Gungor O; Saglam A
Acta Chir Belg; 2007 Jun; 107(3):284-7. PubMed ID: 17685254
[TBL] [Abstract][Full Text] [Related]
37. Quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging to predict lymphovascular invasion and survival outcome in breast cancer.
Lai T; Chen X; Yang Z; Huang R; Liao Y; Chen X; Dai Z
Cancer Imaging; 2022 Oct; 22(1):61. PubMed ID: 36273200
[TBL] [Abstract][Full Text] [Related]
38. Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.
Joseph C; Macnamara O; Craze M; Russell R; Provenzano E; Nolan CC; Diez-Rodriguez M; Sonbul SN; Aleskandarany MA; Green AR; Rakha EA; Ellis IO; Mukherjee A
Br J Cancer; 2018 Apr; 118(8):1142-1151. PubMed ID: 29588513
[TBL] [Abstract][Full Text] [Related]
39. Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study.
Houvenaeghel G; Cohen M; Classe JM; Reyal F; Mazouni C; Chopin N; Martinez A; Daraï E; Coutant C; Colombo PE; Gimbergues P; Chauvet MP; Azuar AS; Rouzier R; Tunon de Lara C; Muracciole X; Agostini A; Bannier M; Charaffe Jauffret E; De Nonneville A; Goncalves A
ESMO Open; 2021 Dec; 6(6):100316. PubMed ID: 34864349
[TBL] [Abstract][Full Text] [Related]
40. Expression signature defined by FOXM1-CCNB1 activation predicts disease recurrence in non-muscle-invasive bladder cancer.
Kim SK; Roh YG; Park K; Kang TH; Kim WJ; Lee JS; Leem SH; Chu IS
Clin Cancer Res; 2014 Jun; 20(12):3233-43. PubMed ID: 24714775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
